Stock Market

Cigniti Technologies Cancels Q4 Results as Coforge Acquires After NCLT Approval

Alex Smith

Alex Smith

2 hours ago

4 min read 👁 1 views
Cigniti Technologies Cancels Q4 Results as Coforge Acquires After NCLT Approval

Synopsis:- With the NCLT formally approving its merger with Coforge, Cigniti Technologies has ceased to exist as an independent listed entity its board meeting scheduled for May 5 was cancelled, its Q4 results will never be declared separately, and shareholders will receive one Coforge share for every Cigniti share they hold.

A nearly decade-long run as an independent, listed quality engineering company came to a close on Monday as a software testing specialist’s board meeting was cancelled following the completion of its court-approved merger. The company now exists only as an absorbed unit within a larger mid-cap IT services firm. Both stocks fell on the session, though the gap between their prices narrowed to just Rs. 4 per share, reflecting market confidence in the 1:1 swap.

With a market capitalisation of approximately Rs. 3,187.18 crore, the shares of Cigniti Technologies were trading at Rs. 1,157 per share, up 0.96 percent from its previous closing price of Rs. 1,146. It is trading at a P/E of 10.45.

The National Company Law Tribunal’s order has given formal effect to the amalgamation, dissolving Cigniti Technologies without winding up and folding it into Coforge. As a direct consequence, Cigniti’s financial results for the January–March 2026 quarter will no longer be reported as a standalone filing. Instead, the performance of the merged entity will be captured within Coforge’s standalone results going forward.

The share exchange ratio is fixed at 1:1; every shareholder holding one Cigniti share of Rs. 10 face value will receive one equity share of Coforge of Rs. 2 face value. The face value difference reflects Coforge’s stock split undertaken in June 2025 and does not affect economic value. At May 5 closing prices, Coforge shares were trading at Rs. 1,153.90, roughly Rs. 4 above Cigniti’s Rs. 1,149.80. That narrow differential, rather than a wider arb gap, suggests the market views the swap as structurally complete with minimal residual uncertainty.

For Coforge, the absorption of Cigniti addresses a specific gap in its client roster. The merger brings 28 additional Fortune 500 clients into the combined entity’s book, along with a specialised presence in healthcare IT and software assurance services areas where Cigniti had built a track record across insurance, banking, and digital transformation mandates. Coforge’s stated target is $2 billion in revenue by FY27, and Cigniti’s billing scale contributes meaningfully toward that ambition.

It is worth noting what investors are absorbing into the Coforge fold. Cigniti’s operating margins had expanded from 7 percent in Q4 FY24 to 17 percent by Q4 FY25, with quarterly net profit reaching Rs. 73 crore. The Dec 2025 quarter showed further improvement: revenue of Rs. 579 crore and net profit of Rs. 80 crore. ROCE stood at 34.1 percent and ROE at 26.0 percent per last available data, both well above typical mid-cap IT benchmarks. Coforge is acquiring a business that was accelerating, not one that was struggling.

Business Overview

Cigniti Technologies, incorporated in 1998 in Hyderabad and listed on both BSE and NSE, was India’s largest independent software testing and quality engineering company. Its services spanned quality assurance, digital assurance, AI-driven test automation, and advisory services across verticals including banking, insurance, retail, and healthcare. For the December 2025 quarter, Cigniti reported consolidated revenue of Rs. 579 crore and net profit of Rs. 80 crore. The company will no longer file independent financial results following the NCLT-approved merger.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Cigniti Technologies Cancels Q4 Results as Coforge Acquires After NCLT Approval appeared first on Trade Brains.

Related Articles